WallStSmart

Coca-Cola European Partners PLC (CCEP)vsMondelez International Inc (MDLZ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Mondelez International Inc generates 88% more annual revenue ($39.30B vs $20.90B). CCEP leads profitability with a 9.3% profit margin vs 6.6%. MDLZ appears more attractively valued with a PEG of 1.01. MDLZ earns a higher WallStSmart Score of 60/100 (C).

CCEP

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 3.3Quality: 4.0
Piotroski: 3/9Altman Z: 1.55

MDLZ

Buy

60

out of 100

Grade: C

Growth: 7.3Profit: 5.5Value: 4.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.60
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPSignificantly Overvalued (-64.8%)

Margin of Safety

-64.8%

Fair Value

$59.24

Current Price

$94.57

$35.33 premium

UndervaluedFair: $59.24Overvalued
MDLZOvervalued (-8.0%)

Margin of Safety

-8.0%

Fair Value

$56.93

Current Price

$60.44

$3.51 premium

UndervaluedFair: $56.93Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.0/10
EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

MDLZ2 strengths · Avg: 8.5/10
Market CapQuality
$78.97B9/10

Large-cap with strong market position

EPS GrowthGrowth
41.3%8/10

Earnings expanding 41.3% YoY

Areas to Watch

CCEP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Debt/EquityHealth
1.503/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MDLZ4 concerns · Avg: 3.5/10
P/E RatioValuation
30.5x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.604/10

Distress zone — elevated risk

Profit MarginProfitability
6.6%3/10

6.6% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on EPS Growth, Return on Equity, Free Cash Flow.

Bull Case : MDLZ

The strongest argument for MDLZ centers on Market Cap, EPS Growth. PEG of 1.01 suggests the stock is reasonably priced for its growth.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : MDLZ

The primary concerns for MDLZ are P/E Ratio, Altman Z-Score, Profit Margin.

Key Dynamics to Monitor

CCEP carries more volatility with a beta of 0.49 — expect wider price swings.

MDLZ is growing revenue faster at 8.2% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLZ scores higher overall (60/100 vs 59/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Mondelez International Inc

CONSUMER DEFENSIVE · CONFECTIONERS · USA

Mondelez International, Inc. is an American multinational confectionery, food, holding and beverage and snack food company based in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?